EUVIMEDEUVIMED entdecken
Crossref

Hepcidin values can help predict the responsiveness of roxadustat for treating anemia in patients with chronic kidney disease

Tatsuya Murata iD, Tatsuhito Fukuoka, Takashi Fujii, Toshiaki Yujiri iD

Laboratory Medicine · 22.11.2025 · 56 (6) · 608-613

DOI: 10.1093/labmed/lmaf005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 31.08.2025. Verfasst von Tatsuya Murata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Science, Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan. Hauptthemen laut MEDLINE: Hepcidins, Renal Insufficiency, Chronic, Anemia, Isoquinolines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are novel therapeutic agents for managing anemia in patients with chronic kidney disease (CKD); however, no clinically viable markers for the anemia-improving effect of HIF-PHI have been reported. Therefore, we evaluated changes in iron metabolism markers and identified predictors of anemia amelioration during HIF-PHi treatment.

Methods

We included 48 patients with CKD not undergoing dialysis: 29 patients receiving epoetin β-pegol, an erythropoiesis-stimulating agent (ESA) and 19 patients receiving roxadustat, an HIF-PHi. Markers of iron metabolism, including hepcidin, were measured during treatments using a widely available automated analyzer.

Results

The hemoglobin levels did not differ substantially between the HIF-PHi and ESA groups. Patients treated with HIF-PHI exhibited lower serum iron, ferritin, transferrin saturation, and hepcidin values and higher unsaturated iron-binding capacity at 1 month than did patients receiving the ESA. Reduced hepcidin levels at 1 month were strongly associated with increased hemoglobin levels at 3 months.

Discussion

Our findings suggest that the hepcidin level, as an initial response, can help predict the responsiveness of the HIF-PHi to anemia in patients with CKD. Measuring hepcidin, an integral indicator of iron metabolism, using standard equipment in general hospital laboratories would be beneficial in routine clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepcidinsRenal Insufficiency, ChronicAnemiaIsoquinolinesGlycineHumansMaleFemaleMiddle AgedAgedBiomarkersHematinicsAged, 80 and overTreatment OutcomeAdult

Stichwörter der Autor:innen

chronic kidney diseasehepcidinhypoxia-inducible factor prolyl hydroxylase inhibitoriron metabolismrenal anemia

Substanzen

HepcidinsroxadustatIsoquinolinesGlycineBiomarkersHematinics

Autor:innen und Institutionen

  • Department of Clinical Laboratory Science, Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
  • Clinical Research Laboratory, JA Hiroshima General Hospital, 1-3-3 Jigozenchou, Hatsukaichi, Hiroshima 738-8503, Japan.

ORCID-Profile: Tatsuya Murata, Toshiaki Yujiri

Zitieren

APA

Murata, T., Fukuoka, T., Fujii, T., & Yujiri, T. (2025). Hepcidin values can help predict the responsiveness of roxadustat for treating anemia in patients with chronic kidney disease. Laboratory Medicine, 56(6), 608-613. https://doi.org/10.1093/labmed/lmaf005

Vancouver

Murata T, Fukuoka T, Fujii T, Yujiri T. Hepcidin values can help predict the responsiveness of roxadustat for treating anemia in patients with chronic kidney disease. Laboratory Medicine. 2025;56(6):608-613. doi:10.1093/labmed/lmaf005

BibTeX
@article{Murata2025,
  author = {Murata, Tatsuya and Fukuoka, Tatsuhito and Fujii, Takashi and Yujiri, Toshiaki},
  title = {Hepcidin values can help predict the responsiveness of roxadustat for treating anemia in patients with chronic kidney disease},
  journal = {Laboratory Medicine},
  year = {2025},
  volume = {56},
  number = {6},
  pages = {608--613},
  doi = {10.1093/labmed/lmaf005}
}
Kostenlos starten →